FSD Pharma Explodes after reporting Positive Q3 Results (OTCQB: FSDDF) (CSE: HUGE) – November 30, 2018 – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) today reported its financial and operational results for the third quarter of fiscal 2018, ended September 30, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com.
Hey guys this is rich from rich tv live and fsd farm i exploded today so i wanted to show you guys why so go to trading view comm you can go to rich tv live.com click on trading view bam trading people pop up click on charts i’m going to quickly look at the chart on fs d df f sd df f sd pharma inc in america huge in canada here we go fs d df once again pop it up
There we go if is d df here we go so you can see that a nice big jump here and if we look at the five-day chart it’s had a really nice run here over the last five days so we’ve seen a low in america of nineteen cents over the last five days we’ve seen the high here of about 32 cents it’s sitting right now at 30 cents it jumped 11% now you’re asking what is the
Catalyst what made this jump okay that’s the american symbol the canadian symbol hu ge my belief is this is just a good company and it’s jumping off a bottom we had it go really high up a lot of people took profits it came back down i mean if you look at the 1-year chart you’ll see it’s been an amazing run up when all the way from august 17th it was at 12 cents
When all the wait as high as 93 cents came all the way down to as low as 26 cents and today hit a high of 42 cents in canada and now we’re at 39 and a half cents up eleven and a half cents so eleven and a half percent so what is the news what is the trigger fsd pharma reports positive q3 results fsd pharma huge in canada fs ddf in america and okay nine in frankfurt
Germany today reported its financial and operational results for the third quarter of fiscal 2018 ended september 30th 2018 these filings are available for review on the kin companies our profile on sedar.com financial and operational highlights for the company mark – mark investment gain of 6.8 million in q3 positive comprehensive earnings per share in q3 of 0.003
Strong cash position exiting september 30 2018 with thirty three point eight million and no debt that’s right no debt a penny stock with no debt successfully achieving transformational milestones of targeting all legal aspects of the cannabis industry including cultivation processing manufacturing extraction and cannabinoid île cannabinoid pharmaceutical research
And development receive license to sell to other licensed producers while also increasing production footprint construction timeline and budget remain in line with expectations for the 200 20,000 square-foot phase 1 expansion at the facility in kohlberg in partnership with oxley cannabis group inc full sales license application in progress for kohlberg facility the
Construction in coburg ontario remains on schedule with cultivation expected to commence in the first half of 2019 the company maintained a strong balance sheet with cash of 33.8 million no debt and continues to execute on the transformational vision of becoming the largest indoor grow facility in the world while also having expertise in processing manufacturing
Extraction and cannabinoid pharmaceutical research and development fsd pharma continues to realize the financial benefits of the strategic investment in the cannabis space which is evidenced by the company’s q3 mark of market profit of 6.8 million for its investment portfolio investments in strategic partners as of september 30 2018 had a market value of 20 point
1 million adding to the strength of the balance sheet the company’s recently added tremendous depth to boost its senior executive team and its board of directors fsd pharma intends to continue to build out its team to ensure a successful transformation into being a global leader in cannabinoid pharmaceutical based treatments and will continue to invest heavily in
Research and development to realize this vision we are pleased with our achievement since going public we continue to work tirelessly toward our goal becoming a global leader in cannabinoid pharmaceutical based treatments says ishaan saeed president and founder of fsd pharma construction with our partners oxley is on schedule and we expect to have our sales license
Shortly that is what we’re waiting for our strong balance sheet affords us the luxury of being able to ensure success as we transform the company into a renowned leader in the cannabinoid pharmaceutical space while building out the largest indoor cultivation facility in the world wow love this company guys i do own 19 thousand shares of fsd pharma i have not been
Compensated for these videos fsd pharma if you’d like to get featured by rich tv live if you’d like to come on the show if you’d like to collaborate holler at your boy we are at wwe tv live.com everything is free here everything that you want to get all the news here free stocks cbds crypto currencies you want to holler at your boy everything’s all right here all
Right there anybody can do this now what do you think about this do you think that huge is gonna go higher now when you look at the investing com technical summary it is a strong buy on the 5-minute chart a strong buy on the hourly chart neutral on the 15 and neutral on the daily chart up 11.2 7% aim monster day for fsd pharma let’s just learn a little bit about
Fsd pharma fsd pharma is focused on the development of the highest quality indoor grown pharmaceutical grade cannabis and on the research and development of novel cannabinoid based treatments for several central nervous system disorders including chronic pain fibromyalgia and irritable bowel syndrome the company’s phase one growth plan involves the development of
25,000 square feet of indoor grow space at its ontario facility and an additional 220,000 square feet which pending approval by health canada is expected to be operational in the first quarter of 2019 that is going to be huge q1 2019 is going to be huge for huge fsd pharma facilities sit on 72 acres of land with 40 acres primed for development on expansion
Capability of up to this is huge three point eight nine six million square feet fst wholly owned subsidiary ff pharma fv pharma is a licensed producer of cannabis having received its cultivation license under the access to cannabis for medical purposes regulations a cmp are otherwise known as green gold on october 13 2017 and is now operating under the recently
Enacted cannabis act the f v pharma vision is to transform its current headquarters in a craft plant in coburg ontario into the largest hydroponic indoor grow facility in the world fv pharma intends to cover all aspects of this exciting new industry including cultivation legal processing manufacturing extracts and research and development and you know what you
Guys are missing you’re missing media you’re missing advertising holler at your boy we’ll get you out there everybody should know about huge everybody should profit with huge remember rich tv live is strictly for education entertainment purposes do your due diligence do your research before you invest in anything that we talk about here i’m rich tv live what do
You think about this bad boy have we seen the bottom is it blue sky from here if you like this video smash the like button comment down below share this video everywhere if i win and you win we all win great day for huge today i’m loving it is your boy rich i’m o huge day for you g it’s true if you’re not winning you’re not watching peace
Transcribed from video
FSD Pharma Explodes after reporting Positive Q3 Results (OTCQB: FSDDF) (CSE: HUGE) ✅🔥🚀💰 By RICH TV LIVE
